ATS Medical, Inc. is dedicated to 'Advancing The Standards' of cardiac
surgery through the development, manufacturing and marketing of innovative
products and services for the treatment of structural heart disease. ATS
Medical, Inc. serves the cardiac surgery community by focusing on two
distinct but operationally synergistic market segments: heart valve disease
therapy and surgical ablation of cardiac arrhythmias.
The ATS 3f brand encompasses an innovative tissue heart valve portfolio.
The ATS Simulus annuloplasty product line assists the surgeon in repairing a
patient's native heart valve as an alternative to replacement. The ATS
CryoMaze products for surgical cryoablation of cardiac arrhythmias.